These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 12215472)
21. Native and oxidized low density lipoproteins oppositely modulate the effects of insulin-like growth factor I on VSMC. González-Timón B; González-Muñoz M; Zaragoza C; Lamas S; Melián EM Cardiovasc Res; 2004 Feb; 61(2):247-55. PubMed ID: 14736541 [TBL] [Abstract][Full Text] [Related]
22. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression. Zhan Y; Kim S; Izumi Y; Izumiya Y; Nakao T; Miyazaki H; Iwao H Arterioscler Thromb Vasc Biol; 2003 May; 23(5):795-801. PubMed ID: 12637337 [TBL] [Abstract][Full Text] [Related]
23. Impairment of collateral formation in lipoprotein(a) transgenic mice: therapeutic angiogenesis induced by human hepatocyte growth factor gene. Morishita R; Sakaki M; Yamamoto K; Iguchi S; Aoki M; Yamasaki K; Matsumoto K; Nakamura T; Lawn R; Ogihara T; Kaneda Y Circulation; 2002 Mar; 105(12):1491-6. PubMed ID: 11914260 [TBL] [Abstract][Full Text] [Related]
24. The mitogenic effect of H2O2 for vascular smooth muscle cells is mediated by an increase of the affinity of basic fibroblast growth factor for its receptor. Herbert JM; Bono F; Savi P FEBS Lett; 1996 Oct; 395(1):43-7. PubMed ID: 8849686 [TBL] [Abstract][Full Text] [Related]
25. Activation of p38 mitogen-activated protein kinase by oxidized LDL in vascular smooth muscle cells: mediation via pertussis toxin-sensitive G proteins and association with oxidized LDL-induced cytotoxicity. Jing Q; Xin SM; Cheng ZJ; Zhang WB; Zhang R; Qin YW; Pei G Circ Res; 1999 Apr; 84(7):831-9. PubMed ID: 10205151 [TBL] [Abstract][Full Text] [Related]
26. Evidence that insulin-like growth factor-1 requires protein kinase C-epsilon, PI3-kinase and mitogen-activated protein kinase pathways to protect human vascular smooth muscle cells from apoptosis. Allen TR; Krueger KD; Hunter WJ; Agrawal DK Immunol Cell Biol; 2005 Dec; 83(6):651-67. PubMed ID: 16266318 [TBL] [Abstract][Full Text] [Related]
27. Protein kinase C-beta mediates lipoprotein-induced generation of PAI-1 from vascular endothelial cells. Ren S; Shatadal S; Shen GX Am J Physiol Endocrinol Metab; 2000 Apr; 278(4):E656-62. PubMed ID: 10751199 [TBL] [Abstract][Full Text] [Related]
28. Differential regulation of extracellular signal-regulated protein kinases (ERKs) 1 and 2 by cAMP and dissociation of ERK inhibition from anti-mitogenic effects in rabbit vascular smooth muscle cells. Cospedal R; Lobo M; Zachary I Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):407-14. PubMed ID: 10455028 [TBL] [Abstract][Full Text] [Related]
29. The role of vascular peroxidase 1 in ox-LDL-induced vascular smooth muscle cell calcification. Tang Y; Xu Q; Peng H; Liu Z; Yang T; Yu Z; Cheng G; Li X; Zhang G; Shi R Atherosclerosis; 2015 Dec; 243(2):357-63. PubMed ID: 26520887 [TBL] [Abstract][Full Text] [Related]
30. Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells. Yoshizumi M; Tsuchiya K; Kirima K; Kyaw M; Suzaki Y; Tamaki T Mol Pharmacol; 2001 Oct; 60(4):656-65. PubMed ID: 11562426 [TBL] [Abstract][Full Text] [Related]
32. Adrenomedullin as a novel growth-promoting factor for cultured vascular smooth muscle cells: role of tyrosine kinase-mediated mitogen-activated protein kinase activation. Iwasaki H; Eguchi S; Shichiri M; Marumo F; Hirata Y Endocrinology; 1998 Aug; 139(8):3432-41. PubMed ID: 9681493 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of the p53 tumor suppressor gene results in growth of human aortic vascular smooth muscle cells. Potential role of p53 in regulation of vascular smooth muscle cell growth. Aoki M; Morishita R; Matsushita H; Hayashi S; Nakagami H; Yamamoto K; Moriguchi A; Kaneda Y; Higaki J; Ogihara T Hypertension; 1999 Aug; 34(2):192-200. PubMed ID: 10454440 [TBL] [Abstract][Full Text] [Related]
34. Low- and high-density lipoproteins as mitogenic factors for vascular smooth muscle cells: individual, additive and synergistic effects. Resink TJ; Bochkov VN; Hahn AW; Philippova MP; Bühler FR; Tkachuk VA J Vasc Res; 1995; 32(5):328-38. PubMed ID: 7578801 [TBL] [Abstract][Full Text] [Related]
35. Angiotensin II-induced growth of vascular smooth muscle cells requires an Src-dependent activation of the epidermal growth factor receptor. Bokemeyer D; Schmitz U; Kramer HJ Kidney Int; 2000 Aug; 58(2):549-58. PubMed ID: 10916078 [TBL] [Abstract][Full Text] [Related]
36. TNF-alpha-induced migration of vascular smooth muscle cells is MAPK dependent. Goetze S; Xi XP; Kawano Y; Kawano H; Fleck E; Hsueh WA; Law RE Hypertension; 1999 Jan; 33(1 Pt 2):183-9. PubMed ID: 9931102 [TBL] [Abstract][Full Text] [Related]
37. Effects of lipoprotein(a) and low density lipoprotein on growth of mitogen-stimulated human umbilical vein endothelial cells. Takahashi A; Taniguchi T; Fujioka Y; Ishikawa Y; Yokoyama M Atherosclerosis; 1996 Feb; 120(1-2):93-9. PubMed ID: 8645376 [TBL] [Abstract][Full Text] [Related]
38. Isorhapontigenin and resveratrol suppress oxLDL-induced proliferation and activation of ERK1/2 mitogen-activated protein kinases of bovine aortic smooth muscle cells. Liu Y; Liu G Biochem Pharmacol; 2004 Feb; 67(4):777-85. PubMed ID: 14757178 [TBL] [Abstract][Full Text] [Related]
39. Amphiregulin is a potent mitogen for the vascular smooth muscle cell line, A7r5. Kato M; Inazu T; Kawai Y; Masamura K; Yoshida M; Tanaka N; Miyamoto K; Miyamori I Biochem Biophys Res Commun; 2003 Feb; 301(4):1109-15. PubMed ID: 12589827 [TBL] [Abstract][Full Text] [Related]